title: The multifaceted functions of C/EBPα in normal and malignant haematopoiesis.
abstract: The process of blood formation, haematopoiesis, depends upon a small number of haematopoietic stem cells (HSCs) that reside in the bone marrow. Differentiation of HSCs is characterised by decreased expression of genes associated with self-renewal accompanied by a stepwise activation of genes promoting differentiation. Lineage branching is further directed by groups of cooperating and counteracting genes forming complex networks of lineage-specific transcription factors. Imbalances in such networks can result in blockage of differentiation, lineage reprogramming and malignant transformation. CCAAT/enhancer-binding protein-α (C/EBPα) was originally identified 30 years ago as a transcription factor that binds both promoter and enhancer regions. Most of the early work focused on the role of C/EBPα in regulating transcriptional processes as well as on its functions in key differentiation processes during liver, adipogenic and haematopoietic development. Specifically, C/EBPα was shown to control differentiation by its ability to coordinate transcriptional output with cell cycle progression. Later, its role as an important tumour suppressor, mainly in acute myeloid leukaemia (AML), was recognised and has been the focus of intense studies by a number of investigators. More recent work has revisited the role of C/EBPα in normal haematopoiesis, especially its function in HSCs, and also started to provide more mechanistic insights into its role in normal and malignant haematopoiesis. In particular, the differential actions of C/EBPα isoforms, as well as its importance in chromatin remodelling and cellular reprogramming, are beginning to be elucidated. Finally, recent work has also shed light on the dichotomous function of C/EBPα in AML by demonstrating its ability to act as both a tumour suppressor and promoter. In the present review, we will summarise the current knowledge on the functions of C/EBPα during normal and malignant haematopoiesis with special emphasis on the recent work.
authors.affiliation: The Finsen Laboratory/Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.|Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.|Danish Stem Cell Centre (DanStem), Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
authors.forename: E
authors.initials: E
authors.lastname: Ohlsson
authors.affiliation: The Finsen Laboratory/Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.|Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.|Danish Stem Cell Centre (DanStem), Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
authors.forename: M B
authors.initials: MB
authors.lastname: Schuster
authors.affiliation: The Finsen Laboratory/Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.|Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.|Danish Stem Cell Centre (DanStem), Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
authors.forename: M
authors.initials: M
authors.lastname: Hasemann
authors.affiliation: The Finsen Laboratory/Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.|Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.|Danish Stem Cell Centre (DanStem), Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
authors.forename: B T
authors.initials: BT
authors.lastname: Porse
mesh_terms: D000818:Animals; D022763:CCAAT-Enhancer-Binding Protein-alpha / Q000378:metabolism*; D019337:Hematologic Neoplasms / Q000503:physiopathology*; D006410:Hematopoiesis / Q000502:physiology*; D006801:Humans
chemical_list: D022763:CCAAT-Enhancer-Binding Protein-alpha